| 000 | 01745 a2200481 4500 | ||
|---|---|---|---|
| 005 | 20250516014350.0 | ||
| 264 | 0 | _c20110202 | |
| 008 | 201102s 0 0 eng d | ||
| 022 | _a1099-1069 | ||
| 024 | 7 |
_a10.1002/hon.943 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aFerrara, Felicetto | |
| 245 | 0 | 0 |
_aContinuous sequential infusion of fludarabine and cytarabine for elderly patients with acute myeloid leukaemia secondary to a previously diagnosed myelodysplastic syndrome. _h[electronic resource] |
| 260 |
_bHematological oncology _cDec 2010 |
||
| 300 |
_a202-8 p. _bdigital |
||
| 500 | _aPublication Type: Clinical Trial; Journal Article | ||
| 650 | 0 | 4 | _aAcute Disease |
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 | _aAged, 80 and over |
| 650 | 0 | 4 |
_aAntineoplastic Combined Chemotherapy Protocols _xadverse effects |
| 650 | 0 | 4 | _aCombined Modality Therapy |
| 650 | 0 | 4 |
_aCytarabine _xadministration & dosage |
| 650 | 0 | 4 |
_aDiarrhea _xchemically induced |
| 650 | 0 | 4 | _aDisease-Free Survival |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 |
_aHematopoietic Stem Cell Transplantation _xmethods |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aInfusions, Intravenous |
| 650 | 0 | 4 |
_aLeukemia, Myeloid _xetiology |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 |
_aMyelodysplastic Syndromes _xcomplications |
| 650 | 0 | 4 | _aRemission Induction |
| 650 | 0 | 4 | _aTransplantation, Autologous |
| 650 | 0 | 4 | _aTreatment Outcome |
| 650 | 0 | 4 |
_aVidarabine _xadministration & dosage |
| 700 | 1 | _aPalmieri, Salvatore | |
| 700 | 1 | _aIzzo, Tiziana | |
| 700 | 1 | _aCriscuolo, Clelia | |
| 700 | 1 | _aRiccardi, Cira | |
| 773 | 0 |
_tHematological oncology _gvol. 28 _gno. 4 _gp. 202-8 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1002/hon.943 _zAvailable from publisher's website |
| 999 |
_c20427422 _d20427422 |
||